abstract |
Methods are provided for treating or preventing Alzheimer's disease comprising mucosally administering β-amyloid peptide or a fragment or analog thereof in an oral or other mucosal dosage form. Also disclosed herein are pharmaceutical formulation or dosage forms for use in these methods. |